Gardner-MedwinJMDolezalovaPCumminsC. Incidence of Henoch-Schonlein purpura, Kawasaki disease and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-1202.
2.
CotchMFHoffmanGSYergDE. The epidemiology of Wegener’s granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996;39:87-92.
3.
StegmayrBGotheforsLMalmerB. Wegener granulomatosis in children and young adults: a case study of ten patients. Pediatr Nephrol. 2000;14:208-213.
4.
AkikusaJDSchneiderRHarveyEA. Clinical features and outcome of pediatric Wegener’s granulomatosis. Arthritis Rheum. 2007;57:837-844.
5.
BelostotskyVMShahVDilonMJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002;17:754-761.
6.
RottemMFauciASHallahanCW. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993;122:26-31.
7.
EustaquioMEChanKHDeterdingRR. Multilevel airway involvement in children with Wegener’s granulomatosis. Arch Otolaryngol Head Neck Surg. 2011;137:480-485.
8.
FroschMFoellD. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163:425-434.
9.
OzenSPistorioAIusanSM. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis. Ann Rheum Dis. 2010;69:798-806.
10.
HoffmanGSKerrGSLeavittRY. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
NilesJLMcCluskeyRTAhmadMF. Wegeners granulomatosis autoantigen is a novel neutrophil serine protease. Blood. 1989;74:1888-1893.
13.
SnellerMCHoffmanGSTalar-WilliamsC. An analysis of forty-two Wegener’s granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 1995;38:608-613.
14.
GuillevinLCordierJFLhoteF. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum. 1997;40:2187-2198.
15.
PagnouxCMahrAHamidouMA. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359:2790-2803.
16.
Reinhold-KellerEBegueNLatzaU. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021-1032.
17.
KoldingsnesWNossentJC. Baseline features and initial treatment as predictors of remission and relapse in Wegner granulomatosis. J Rheumatol. 2003;30:80-88.
18.
SlotMCTervaertJWFranssenCF. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670.
19.
NeumannIKainRRegeleH. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. 2005;20:96-104.
